Clinical Trial Update: A Trial of TH-302 in Combination With Doxorubicin Versus Doxorubicin Alone to Treat Patients With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing TH-302 plus doxorubicin to doxorubicin alone in patients with locally advanced unresectable or metastatic soft tissue sarcoma has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Doxorubicin (doxorubicin)
• TH-302 (evofosfamide)

Snippet

Sponsor: Threshold Pharmaceuticals | Conditions: Soft Tissue Sarcoma | Phase 3 | Status: COMPLETED